What is NDC 0024-5862?

0024-5862 is the product NDC for Mozobil (plerixafor), Plerixafor 24 mg/1.2mL injection, solution, listed with the FDA by Sanofi-Aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Sanofi-Aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mozobil?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mozobil NDC 0024-5862 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0024-5862Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00024-5862Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0024-5862-01	0002458620100024586201	1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01) / 1.2 mL in 1 VIAL, SINGLE-USEMarketed from Sep 1, 2013

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mozobil
Generic name (nonproprietary): plerixafor
Active ingredients: Plerixafor — 24 mg/1.2mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Sanofi-Aventis U.S. LLCNDC labeler code 0024
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022311
Marketing start: Sep 1, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Increased Hematopoietic Stem Cell Mobilization (Physiologic effect)
Identifiers: Product ID 0024-5862_fec4102e-2c66-433f-ab6c-7f420b4c3a86SPL ID fec4102e-2c66-433f-ab6c-7f420b4c3a86SPL set ID 0ed08d2b-5051-46b2-aa37-1d6275bf9003RxCUI 828700, 828703UNII S915P5499N
Pharmacologic class: Hematopoietic Stem Cell Mobilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400024586201 followed by a unit qualifier and the quantity

Package 00024-5862-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 22, 2025.

Indications (excerpt from the label)

Mozobil is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM). Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0024-5862

What is NDC 0024-5862?: 0024-5862 is the product NDC for Mozobil (plerixafor), Plerixafor 24 mg/1.2mL injection, solution, listed with the FDA by Sanofi-Aventis U.S. LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mozobil (Plerixafor).
What is the active ingredient?: Plerixafor.
Who is the labeler?: Sanofi-Aventis U.S. LLC, NDC labeler code 0024. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mozobil?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 022311

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022311
Product	Strength	Form · route	Labeler	Product NDC
Plerixafor	Plerixafor 24 mg/1.2mL	Injection, SolutionSubcutaneous	Fresenius Kabi Usa, LLC	65219-284

Mozobil (Plerixafor) NDC 0024-5862